Maryland was the first state to enact a PDAB in 2019. Maryland’s PDAB has also issued UPLs that are not yet implemented. of Marylanders would be affected. The Maryland Board was the first PDAB enacted, yet it has generated no savings. Colorado, Maryland, and Oregon were highlighted because of their notable activity.

Maryland PDAB: How to Follow the Letter of the Law While Breaking Its Spirit Maryland's Prescription On March 18, 2025, the Maryland PDAB posted a revised agenda for their upcoming March 24 meeting. The Maryland PDAB's approach creates a veneer of public engagement while practically guaranteeing that The Maryland case isn't an anomaly. From Maryland's last-minute document dumps to Colorado's refusal to conduct impact analyses and Oregon's

This quarter’s research revealed that Missouri and Maryland have reintroduced fibrosis-scoring requirements state Medicaid programs that now have fibrosis staging as a requirement for HCV treatment approval: Maryland

enacting PDAB legislation: Washington, Oregon, Colorado, Michigan, Minnesota, New Jersey, New Hampshire, Maryland have the ability to enact binding upper payment limit (UPL) settings: Washington, Oregon, Colorado, Maryland

on the total number of drugs on each state's "Eligible for Review" list (or "Selected for Review" in Maryland's In Maryland and Oregon, every drug eligible for review falls into these categories. Maryland's PDAB focuses on endocrine disorders, autoimmune disorders, and respiratory disorders.

massive coalition of 60 entities, including a nurses’ union, and startling data supporting the need for Maryland While Maryland already had certain patient protections from these predatory practices on the books, too

the medicines at a discount to other co-conspirators running distribution companies in Mississippi, Maryland

In spite of this, Colorado and Maryland, two states that have set UPLs, did not engage in any interdepartmental

In Maryland, carriers requested 17.1% increases, but rates would drop to 7.9% if Congress extends enhanced

A Maryland patient living with HIV received Gilead's Biktarvy shipped from Turkey, the bottle labeled

massive overcharges: Ohio lost $224.8 million in one year, Pennsylvania $605 million over four years, and Maryland

prerequisites, yet some are rebuilding barriers through step therapy and non-preferred drug status, as Maryland